Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2025-12-24 @ 11:30 PM
NCT ID:
NCT00607256
Brief Summary:
To evaluate the lon-term safety and tolerability of \[S,S\]-reboxetine in patients with fibromyalgia
Study:
NCT00607256
Study Brief:
Protocol Section:
NCT00607256